IMM 3.73% 32.3¢ immutep limited

new hope for ovarian sufferers, page-16

  1. 1,217 Posts.
    lightbulb Created with Sketch. 16
    agree with Philbar, here is another link

    http://www.mimosa-study.com/abagovomab_faq_frame.htm

    it sounds promising but words like "not yet conclusive" and "efficiacy results not due til first half of 2011" dont make me want to dump my PRR shares.

    I am all for finding treatments for this terrible disease but again definitely dyor on peoples comments on here. There are always motives, and why certain people are posting about another treatment on here and ramping it up on a PRR thread is beyond me.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.